Cargando…

Ex Vivo Evaluation of Glutamine Treatment in Sepsis and Trauma in a Human Peripheral Blood Mononuclear Cells Model

We aimed to assess the lipopolysaccharide (LPS), or heat shock (HS) induction, and glutamine-modulating effects on heat shock protein-90α (HSP90α) and cytokines in an ex vivo model using peripheral blood mononuclear cells (PBMCs). The PBMCs of patients with septic shock, trauma-related systemic infl...

Descripción completa

Detalles Bibliográficos
Autores principales: Briassouli, Efrossini, Tzanoudaki, Marianna, Goukos, Dimitris, Vardas, Kostas, Briassoulis, Panagiotis, Ilia, Stavroula, Kanariou, Maria, Routsi, Christina, Nanas, Serafim, Daikos, George L., Briassoulis, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9824313/
https://www.ncbi.nlm.nih.gov/pubmed/36615909
http://dx.doi.org/10.3390/nu15010252
_version_ 1784866379021680640
author Briassouli, Efrossini
Tzanoudaki, Marianna
Goukos, Dimitris
Vardas, Kostas
Briassoulis, Panagiotis
Ilia, Stavroula
Kanariou, Maria
Routsi, Christina
Nanas, Serafim
Daikos, George L.
Briassoulis, George
author_facet Briassouli, Efrossini
Tzanoudaki, Marianna
Goukos, Dimitris
Vardas, Kostas
Briassoulis, Panagiotis
Ilia, Stavroula
Kanariou, Maria
Routsi, Christina
Nanas, Serafim
Daikos, George L.
Briassoulis, George
author_sort Briassouli, Efrossini
collection PubMed
description We aimed to assess the lipopolysaccharide (LPS), or heat shock (HS) induction, and glutamine-modulating effects on heat shock protein-90α (HSP90α) and cytokines in an ex vivo model using peripheral blood mononuclear cells (PBMCs). The PBMCs of patients with septic shock, trauma-related systemic inflammatory response syndrome (SIRS), and healthy subjects were incubated with 1 μg/mL LPS at 43 °C (HS). Glutamine 10 mM was added 1 hour before or after induction or not at all. We measured mRNA HSP90α, monocyte (m) and lymphocyte (l) HSP90α proteins, interleukin (IL)-1b, -6, -8, -10, tumor necrosis factor-α (TNF-α), and monocyte chemoattractant protein-1 (MCP-1) supernatant levels. Heat shock increased the HSP90α mRNA and mHSP90α in all groups (10-fold in sepsis, p < 0.001 and p = 0.047, respectively). LPS induced the mHSP90α and lHSP90α in healthy (p < 0.001) and mHSP90α in SIRS (p = 0.004) but not in sepsis. LPS induced the cytokines at 24 and 48 h in all groups, especially in trauma (p < 0.001); HS only induced the IL-8 in healthy (p = 0.003) and septic subjects (p = 0.05). Glutamine at 10 mM before or after stimulation did not alter any induction effect of LPS or HS on HSP90α mRNA and mHSP90α protein in sepsis. In SIRS, glutamine before LPS decreased the mHSP90α but increased it when given after HS (p = 0.018). Before or after LPS (p = 0.049) and before HS (p = 0.018), glutamine decreased the lHSP90α expression in sepsis but increased it in SIRS when given after HS (p = 0.003). Regarding cytokines, glutamine enhanced the LPS-induced MCP-1 at 48 h in healthy (p = 0.011), SIRS (p < 0.001), and sepsis (p = 0.006). In conclusion, glutamine at 10 mM, before or after LPS and HS, modulates mHSP90α and lHSP90α in sepsis and SIRS differently and unpredictably. Although it does not alter the stimulation effect on interleukins, glutamine enhances the LPS induction effect on supernatant MCP-1 in all groups. Future research should seek to elucidate better the impact of glutamine and temperature modulation on HSP90α and MCP-1 pathways in sepsis and trauma.
format Online
Article
Text
id pubmed-9824313
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-98243132023-01-08 Ex Vivo Evaluation of Glutamine Treatment in Sepsis and Trauma in a Human Peripheral Blood Mononuclear Cells Model Briassouli, Efrossini Tzanoudaki, Marianna Goukos, Dimitris Vardas, Kostas Briassoulis, Panagiotis Ilia, Stavroula Kanariou, Maria Routsi, Christina Nanas, Serafim Daikos, George L. Briassoulis, George Nutrients Article We aimed to assess the lipopolysaccharide (LPS), or heat shock (HS) induction, and glutamine-modulating effects on heat shock protein-90α (HSP90α) and cytokines in an ex vivo model using peripheral blood mononuclear cells (PBMCs). The PBMCs of patients with septic shock, trauma-related systemic inflammatory response syndrome (SIRS), and healthy subjects were incubated with 1 μg/mL LPS at 43 °C (HS). Glutamine 10 mM was added 1 hour before or after induction or not at all. We measured mRNA HSP90α, monocyte (m) and lymphocyte (l) HSP90α proteins, interleukin (IL)-1b, -6, -8, -10, tumor necrosis factor-α (TNF-α), and monocyte chemoattractant protein-1 (MCP-1) supernatant levels. Heat shock increased the HSP90α mRNA and mHSP90α in all groups (10-fold in sepsis, p < 0.001 and p = 0.047, respectively). LPS induced the mHSP90α and lHSP90α in healthy (p < 0.001) and mHSP90α in SIRS (p = 0.004) but not in sepsis. LPS induced the cytokines at 24 and 48 h in all groups, especially in trauma (p < 0.001); HS only induced the IL-8 in healthy (p = 0.003) and septic subjects (p = 0.05). Glutamine at 10 mM before or after stimulation did not alter any induction effect of LPS or HS on HSP90α mRNA and mHSP90α protein in sepsis. In SIRS, glutamine before LPS decreased the mHSP90α but increased it when given after HS (p = 0.018). Before or after LPS (p = 0.049) and before HS (p = 0.018), glutamine decreased the lHSP90α expression in sepsis but increased it in SIRS when given after HS (p = 0.003). Regarding cytokines, glutamine enhanced the LPS-induced MCP-1 at 48 h in healthy (p = 0.011), SIRS (p < 0.001), and sepsis (p = 0.006). In conclusion, glutamine at 10 mM, before or after LPS and HS, modulates mHSP90α and lHSP90α in sepsis and SIRS differently and unpredictably. Although it does not alter the stimulation effect on interleukins, glutamine enhances the LPS induction effect on supernatant MCP-1 in all groups. Future research should seek to elucidate better the impact of glutamine and temperature modulation on HSP90α and MCP-1 pathways in sepsis and trauma. MDPI 2023-01-03 /pmc/articles/PMC9824313/ /pubmed/36615909 http://dx.doi.org/10.3390/nu15010252 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Briassouli, Efrossini
Tzanoudaki, Marianna
Goukos, Dimitris
Vardas, Kostas
Briassoulis, Panagiotis
Ilia, Stavroula
Kanariou, Maria
Routsi, Christina
Nanas, Serafim
Daikos, George L.
Briassoulis, George
Ex Vivo Evaluation of Glutamine Treatment in Sepsis and Trauma in a Human Peripheral Blood Mononuclear Cells Model
title Ex Vivo Evaluation of Glutamine Treatment in Sepsis and Trauma in a Human Peripheral Blood Mononuclear Cells Model
title_full Ex Vivo Evaluation of Glutamine Treatment in Sepsis and Trauma in a Human Peripheral Blood Mononuclear Cells Model
title_fullStr Ex Vivo Evaluation of Glutamine Treatment in Sepsis and Trauma in a Human Peripheral Blood Mononuclear Cells Model
title_full_unstemmed Ex Vivo Evaluation of Glutamine Treatment in Sepsis and Trauma in a Human Peripheral Blood Mononuclear Cells Model
title_short Ex Vivo Evaluation of Glutamine Treatment in Sepsis and Trauma in a Human Peripheral Blood Mononuclear Cells Model
title_sort ex vivo evaluation of glutamine treatment in sepsis and trauma in a human peripheral blood mononuclear cells model
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9824313/
https://www.ncbi.nlm.nih.gov/pubmed/36615909
http://dx.doi.org/10.3390/nu15010252
work_keys_str_mv AT briassouliefrossini exvivoevaluationofglutaminetreatmentinsepsisandtraumainahumanperipheralbloodmononuclearcellsmodel
AT tzanoudakimarianna exvivoevaluationofglutaminetreatmentinsepsisandtraumainahumanperipheralbloodmononuclearcellsmodel
AT goukosdimitris exvivoevaluationofglutaminetreatmentinsepsisandtraumainahumanperipheralbloodmononuclearcellsmodel
AT vardaskostas exvivoevaluationofglutaminetreatmentinsepsisandtraumainahumanperipheralbloodmononuclearcellsmodel
AT briassoulispanagiotis exvivoevaluationofglutaminetreatmentinsepsisandtraumainahumanperipheralbloodmononuclearcellsmodel
AT iliastavroula exvivoevaluationofglutaminetreatmentinsepsisandtraumainahumanperipheralbloodmononuclearcellsmodel
AT kanarioumaria exvivoevaluationofglutaminetreatmentinsepsisandtraumainahumanperipheralbloodmononuclearcellsmodel
AT routsichristina exvivoevaluationofglutaminetreatmentinsepsisandtraumainahumanperipheralbloodmononuclearcellsmodel
AT nanasserafim exvivoevaluationofglutaminetreatmentinsepsisandtraumainahumanperipheralbloodmononuclearcellsmodel
AT daikosgeorgel exvivoevaluationofglutaminetreatmentinsepsisandtraumainahumanperipheralbloodmononuclearcellsmodel
AT briassoulisgeorge exvivoevaluationofglutaminetreatmentinsepsisandtraumainahumanperipheralbloodmononuclearcellsmodel